Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Large-scale testing (Phase 3)Study completedNCT03386474
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 151
Large-scale testing (Phase 3)Study completedNCT05604989
What this trial is testing

Associations Between the Oral and Intestinal Microbiome and Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Seoul National University Bundang Hospital 45
Large-scale testing (Phase 3)Study completedNCT00100009
What this trial is testing

Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 30
Post-approval studies (Phase 4)UnknownNCT02681783
What this trial is testing

PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept

Who this might be right for
Central Serous ChorioretinopathyAge Related Macular DegenerationIdiopathic Poplypoidal Choroidal Vasculopathy
Sunnybrook Health Sciences Centre 90
Large-scale testing (Phase 3)WithdrawnNCT04697953
What this trial is testing

Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals
Not applicableUnknownNCT01608113
What this trial is testing

Long-term Follow-up of Subfoveal Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Vienna 70
Post-approval studies (Phase 4)Study completedNCT01453920
What this trial is testing

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 44
Not applicableStudy completedNCT04891835
What this trial is testing

Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann

Who this might be right for
Age-related Macular Degeneration
Laurence Postelmans 36
Testing effectiveness (Phase 2)Study completedNCT04640272
What this trial is testing

A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06856577
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 311
Post-approval studies (Phase 4)Ended earlyNCT00134667
What this trial is testing

Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 360
Testing effectiveness (Phase 2)Ended earlyNCT02222207
What this trial is testing

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Bayer 52
Testing effectiveness (Phase 2)UnknownNCT00996684
What this trial is testing

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
University of California, Los Angeles 30
Large-scale testing (Phase 3)Study completedNCT01908816
What this trial is testing

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

Who this might be right for
Choroidal NeovascularizationMacular EdemaGlaucoma, Neovascular+1 more
Novartis Pharmaceuticals 270
Post-approval studies (Phase 4)Ended earlyNCT04563299
What this trial is testing

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Retina Vitreous Associates of Florida 10
Post-approval studies (Phase 4)Looking for participantsNCT05093374
What this trial is testing

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Who this might be right for
Exudative Macular Degeneration
Medical University of Vienna 290
Not applicableStudy completedNCT00858208
What this trial is testing

Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.

Who this might be right for
Neovascular Age-related Macular Degeneration
Pfizer 86
Testing effectiveness (Phase 2)Study completedNCT01242254
What this trial is testing

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 36
Testing effectiveness (Phase 2)Looking for participantsNCT07587515
What this trial is testing

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Eyconis INC. 30
Next Page